In fact, amelioration of motor deficits and reduction in dopaminergic neuronal loss in a mouse model of Parkinson’s disease (PD) may be achieved via regulating FFA3R expression in the enteric nervous system by the bacteria that inhabit the gut [46]. Here, FFAR3 is linked to Parkinson disease.